Phase II trial of adjuvant chemotherapy with carboplatin plus TS1 followed by maintenance TS1 in patients with completely resected stage II/IIIA non-small cell lung cancer. (JNETS1302)
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000011306
- Lead Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group (JNETS)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
1. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray 2. With history of radiotherapy and/or chemotherapy for other disease including other cancer 3. With synchronous or metachronous (within 5 year before entry) multiple lung cancer 4. With synchronous or metachronous (within 5 year before entry) double cancer, except for curable cancer by local therapy such as in situ carcinoma 5. Severe surgical complication 6. Severe drug allergy 7. Severe complication; such as uncontrollable diabetes mellitus or hypertension 8. Positive for HBs antigen, HBs antibody, HBC antibody, HCV antibody or HIV antibody 9.Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 10. Men who have willing to become partner's pregnant 11.Physician concludes that the patient's participation in this trial is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method